FDA Inspection 1264447 — NuCare Pharmaceuticals Inc

NuCare Pharmaceuticals Inc — FEI 3003294404

The FDA completed an inspection of NuCare Pharmaceuticals Inc on Mar 12, 2025 in Orange, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Orange, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.